TruAlt Bioenergy Board of Directors
Get the latest insights into the leadership at TruAlt Bioenergy. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Yagati Badarinarayana Ramakrishna | Chairman |
| Vijaykumar Murugesh Nirani | Managing Director |
| Vishal Nirani | Executive Director |
| Anand Murugan Jakkampati Durairaj | Executive Director |
| Sushmitha Vijaykumar Nirani | Non Executive Director |
| Mallikarjun Bhimappa Dyaberi | Non Executive Independent Director |
| Kanekal Chandrasekhar | Non Executive Independent Director |
| Monu Kumar | Company Secretary and Compliance Officer |
TruAlt Bioenergy FAQs
The board at TruAlt Bioenergy consists of experienced professionals, including Yagati Badarinarayana Ramakrishna, Vijaykumar Murugesh Nirani, and others, overseeing the company’s strategic and corporate governance.
Directors at TruAlt Bioenergy are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Yagati Badarinarayana Ramakrishna is the current chairman at TruAlt Bioenergy.
Executive directors at TruAlt Bioenergy are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, TruAlt Bioenergy adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At TruAlt Bioenergy, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
